CYTR Stock | News | Quote | Stock Forum | Friday, December 13,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$CYTR CytRx Corp. CYTR Company Overview 

CytRx Corp. CYTR Current Price and Quotes
Last Price 6.12
Previous Close 4.02 Open 4.02
Daily Range 6.36 - 3.83 52wk Range 4.38 - 1.80
Volume 31,023,900 Dividend N/A
Average Vol (3m) 1,128,557 Yield N/A

CYTR Stock Message Board http://investorshangout.com/search?q=CYTR&...mp;yt1=Go!

Last Updated: Friday, December 13, 2013 01:19:45 AM

CytRx Corp. CYTR
Company Information

11726 San Vicente Boulevard
Suite 650
Los Angeles, CA 90049

Phone: (310) 826-5648

CytRx Corp. CYTR
Not Available

CytRx Corp. CYTR
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000799698
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Atlanta, GA, 30344
United States


CytRx Corp. CYTR
CYTR Security Details

Share Structure

Market Value1 $104,518,776 a/o Dec 12, 2013
Shares Outstanding 41,975,412 a/o Oct 29, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record Not Available
Security Notes

New Issue=11-86 6,000,000 shs in units (3 shs Com & 3 Class A Warr 11-9-91) at $6 per unit by D.H. Blair & Co., Inc.
Capital Change=Capital Change=shs decreased by 1 for 4 split. Ex-date=02/06/1996. Rec date=02/06/1996. Pay date=02/06/1996.
Capital Change=shs decreased by 1 for 7 split. Ex-date=05/16/2012.
Short Selling Data

Short Interest 3,265,454 (-3.06%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

CytRx Corp. CYTR Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 100 250 100 9,500
Cost of Revenue - - - -
Gross Profit 100 250 100 9,500
Operating Expenses

Research and Development 12,685 15,491 8,507 7,542
Sales, General and Admin. 8,353 7,317 8,236 9,128
Non-Recurring Items - - - -
Other 114 96 108 475
Operating Income (21,052) (22,654) (16,751) (7,645)
Income From Continuing Operations

Add'l Income/Expense Items 3,090 8,327 17,159 2,325
Earnings Before Interest and Tax (17,962) (14,327) 408 (5,319)
Interest Expense - - - -
Earnings Before Tax (17,962) (14,327) 408 (5,319)
Income Tax 2 98 - (519)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,964) (14,425) 408 (4,800)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,964) (14,425) 408 (4,800)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,964) (14,425) 408 (4,800)

CytRx Corp. CYTR Recent News

Dec 11, 2013 Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc
Dec 11, 2013 CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial
Dec 10, 2013 CytRx to Hold Conference Call December 11, 2013 at 10:30 a.m. Eastern Time to Discuss Results of Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas
Dec 4, 2013 CytRx Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11th, 2013
Nov 26, 2013 CytRx to Present at the Sixth Annual LD MICRO "Main Event" Conference in Los Angeles on December 3, 2013
Nov 20, 2013 CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer)
Nov 7, 2013 MissionIR Releases Exclusive Audio Interview With CytRx Management
Oct 31, 2013 CytRx Reports Further Positive Interim Data from Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas
Oct 29, 2013 CytRx Reports 2013 Third Quarter Financial Results
Oct 25, 2013 Hot Topic: Breast Cancer Awareness Month 2013

1
2
next >

CYTR CytRx Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CYTR&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CYTR/quote
Stock Chart http://www.otcmarkets.com/stock/CYTR/chart
Company Info http://www.otcmarkets.com/stock/CYTR/company-info
Recent News http://www.otcmarkets.com/stock/CYTR/news
Financials http://www.otcmarkets.com/stock/CYTR/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CYTR/filings
Short Sales http://www.otcmarkets.com/stock/CYTR/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CYTR/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CYTR/research
Summary http://finance.yahoo.com/q?s=CYTR
Historical Prices http://finance.yahoo.com/q/hp?s=CYTR+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CYTR
Basic Chart http://finance.yahoo.com/q/bc?s=CYTR+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CYTR+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CYTR+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CYTR+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CYTR+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CYTR+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CYTR+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CYTR+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CYTR+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CYTR+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CYTR
Balance Sheet http://finance.yahoo.com/q/bs?s=CYTR
Cash Flow http://finance.yahoo.com/q/cf?s=CYTR+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CYTR
Market Watch http://www.marketwatch.com/investing/stock/CYTR
Bloomberg http://www.bloomberg.com/quote/CYTR:US
Morningstar http://quotes.morningstar.com/stock/s?t=CYTR
Bussinessweek http://investing.businessweek.com/research/st...icker=CYTR
Barchart http://www.barchart.com/quotes/stocks/CYTR
OTC Short Report http://otcshortreport.com/index.php?index=CYTR
Investopedia http://www.investopedia.com/markets/stocks/CYTR/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 0

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Balavant Insurance Group Welcomes John Jankowski as CIO

Updated Category News Views 317

Leadership Appointment at Balavant Insurance Group Balavant Insurance Group has made a significant move by appointing John Jankowski as its new Chief Information Officer. This announcement marks a pivotal moment for the company, known for its focus on technological advancement and innovative insurance solutions. Strategic Role of the Chief Information Officer In his role,...

Continue Reading
Exploring the Growth of the Industrial Absorbent Sector

Updated Category News Views 245

Understanding the Industrial Absorbent Market Dynamics The industrial absorbent market is poised for remarkable growth, expected to reach $5.50 billion by 2031. This growth trajectory aligns with a compound annual growth rate (CAGR) of 4.3%. The increase in market size is largely driven by the rising usage of absorbents across various industries in response to...

Continue Reading
ChoiceOne Financial Services Achieves Successful Bank Merger

Updated Category News Views 147

Successful Bank Merger by ChoiceOne Financial Services ChoiceOne Financial Services, Inc. (NASDAQ: COFS), the parent company of ChoiceOne Bank, has achieved a significant milestone by completing the consolidation of The State Bank into ChoiceOne Bank. This strategic move empowers the strength of ChoiceOne, further enhancing its service capabilities and market presence. A...

Continue Reading
Danantara Indonesia and INA Forge Nickel Investment Alliance with Eramet

Updated Category News Views 443

Strategic Collaboration for Nickel Development In a significant move to bolster the nickel downstream industry, partners including Danantara Indonesia and the Indonesia Investment Authority (INA) have officially signed a Memorandum of Understanding (MoU) with the prominent French mining company, Eramet. This collaboration aims to create an extensive investment platform...

Continue Reading
Full Moon Bar-B-Que's Generous Initiative for Local Kids

Updated Category News Views 180

Full Moon Bar-B-Que's Generosity In a heartwarming gesture, Full Moon Bar-B-Que has made a significant impact on the community by contributing $200,000 worth of backpacks and school supplies. Their ongoing commitment through the Backpack Blessings program is not just about donations; it's about nurturing and empowering local children who need support the most. Supporting...

Continue Reading